SGHT
Sight Sciences, Inc. · Healthcare
Director Staffan Encrantz bought $12.6M of Sight Sciences, Inc.
Bought$12,649,152
$24.00Price
527,048Shares
+15%Stake
What SGHT did for a copier
Prices for SGHT after this filing aren't in yet.
Staffan Encrantz's record
9 other buys with 3 months of prices since 2021: on average −6.4% against the S&P 500, and 3 of 9 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Oct 18. Filed Wed, Oct 20, 8:30 PM ET, after the close. Not investment advice.